中国中药(00570)上涨2.1%,报2.43元/股

金融界
25 Oct 2024

10月25日,中国中药(00570)盘中上涨2.1%,截至14:18,报2.43元/股,成交3.11亿元。

中国中药控股有限公司是国药集团的核心平台,主要业务涵盖中药材种采、中药饮片、配方颗粒、中成药、中医药大健康等相关领域,拥有800多个成药品规和700多个单味中药配方颗粒品种。公司员工约1.8万人,拥有超过100家子公司,以及“冯了性”、“安宁”、“同济堂”3个中华老字号和5个驰名商标。

截至2024年中报,中国中药营业总收入83.85亿元、净利润2.11亿元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10